Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.95.20.12022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-Tyrosine Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Is There a Role for Dacomitinib, a Second-Generation Irreversible Inhibitor of the Epidermal-Growth Factor Receptor Tyrosine Kinase, in Advanced Non-Small Cell Lung Cancer?

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2020English

ZD1839 (‘Iressa’), a Specific Oral Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, Potentiates Radiotherapy in a Human Colorectal Cancer Xenograft Model

British Journal of Cancer
Cancer ResearchOncology
2002English

Insulin-Like Growth Factor-I Receptor Blockade by a Specific Tyrosine Kinase Inhibitor for Human Gastrointestinal Carcinomas

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Lung Cancer Cells Survive Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Exposure Through Upregulation of Cholesterol Synthesis

FASEB BioAdvances
2019English

Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study

Biomedical Journal
Medicine
2015English

Local Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor May Provide a New Therapeutic Potential for the Treatment of Intractable Upper Airway Inflammation

Journal of Japan Society of Immunology & Allergology in Otolaryngology
2016English

Genetic Alterations in Epidermal Growth Factor Receptor‑tyrosine Kinase Inhibitor‑na�ve Non‑small Cell Lung Carcinoma

Oncology Letters
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy